Neuroserpin: a selective inhibitor of tissue-type plasminogen activator in the central nervous systemYEPES, Manuel; LAWRENCE, Daniel A.Thrombosis and haemostasis. 2004, Vol 91, Num 3, pp 457-464, issn 0340-6245, 8 p.Conference Paper

The tissue-type plasminogen activator― plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humansSASHINDRANATH, Maithili; SALES, Eunice; ROSENFELD, Jeffrey V et al.Brain. 2012, Vol 135, pp 3251-3264, issn 0006-8950, 14 p., 11Article

Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosisDIAZ, Jose A; BALLARD-LIPKA, Nicole E; FARRIS, Diana M et al.Journal of vascular surgery. 2012, Vol 55, Num 3, pp 815-822, issn 0741-5214, 8 p.Article

Multifaceted Role of Plasminogen Activator Inhibitor-1 in Regulating Early Remodeling of Vein Bypass GraftsYAN JI; STRAWN, Tammy L; GRUNZ, Elizabeth A et al.Arteriosclerosis, thrombosis, and vascular biology. 2011, Vol 31, Num 8, pp 1781-1787, issn 1079-5642, 7 p.Article

Visceral Adipose Tissue Inflammation Accelerates Atherosclerosis in Apolipoprotein E-Deficient MiceÖHMAN, Miina K; YUECHUN SHEN; OBIMBA, Chinyere I et al.Circulation (New York, N.Y.). 2008, Vol 117, Num 6, pp 798-805, issn 0009-7322, 8 p.Article

Tissue plasminogen activator and neuroserpin are widely expressed in the human central nervous systemTEESALU, Tambet; KULLA, Andres; SIMISKER, Aadu et al.Thrombosis and haemostasis. 2004, Vol 92, Num 2, pp 358-368, issn 0340-6245, 11 p.Article

Progressive Ankylosis (ank) protein is expressed by neurons and Ank immunohistochemical reactivity is increased by limbic seizuresYEPES, Manuel; MOORE, Elizabeth; BROWN, Sharron A. N et al.Laboratory investigation. 2003, Vol 83, Num 7, pp 1025-1032, issn 0023-6837, 8 p.Article

PAI-1 promotes the accumulation of exudate macrophages and worsens pulmonary fibrosis following type II alveolar epithelial cell injuryOSTERHOLZER, John J; CHRISTENSEN, Paul J; OLSZEWSKI, Michal A et al.Journal of pathology (Print). 2012, Vol 228, Num 2, pp 170-180, issn 0022-3417, 11 p.Article

Mechanisms underlying the antifibrotic properties of noninhibitory PAI-1 (PAI-1R) in experimental nephritisYUFENG HUANG; BORDER, Wayne A; LAWRENCE, Daniel A et al.American journal of physiology. Renal physiology. 2009, Vol 66, Num 4, issn 1931-857X, F1045-F1054Article

A soluble Fn14-Fc decoy receptor reduces infarct volume in a murine model of cerebral ischemiaYEPES, Manuel; BROWN, Sharron A. N; MOORE, Elizabeth G et al.The American journal of pathology. 2005, Vol 166, Num 2, pp 511-520, issn 0002-9440, 10 p.Article

Association between conformational mutations in neuroserpin and onset and severity of dementiaDAVIS, Richard L; SHRIMPTON, Antony E; PICCARDO, Pedro et al.Lancet (British edition). 2002, Vol 359, Num 9325, pp 2242-2247, issn 0140-6736Article

Neuroserpin mutation S52R causes Neuroserpin accumulation in neurons and is associated with progressive myoclonus epilepsyTAKAO, Masaki; BENSON, Merrill D; FARLOW, Martin R et al.Journal of neuropathology and experimental neurology. 2000, Vol 59, Num 12, pp 1070-1086, issn 0022-3069Article

Taming Neonatal Hypoxic―Ischemic Brain Injury by Intranasal Delivery of Plasminogen Activator Inhibitor-1YANG, Dianer; SUN, Yu-Yo; XIAOYI LIN et al.Stroke (1970). 2013, Vol 44, Num 9, pp 2623-2627, issn 0039-2499, 5 p.Article

Recombinant Plasminogen Activator Inhibitor-1 Inhibits Intimal HyperplasiaJIANBO WU; LIN PENG; MCMAHON, Grainne A et al.Arteriosclerosis, thrombosis, and vascular biology. 2009, Vol 29, Num 10, pp 1565-1570, issn 1079-5642, 6 p.Article

A PAI-1 Mutant, PAI-1R, Slows Progression of Diabetic NephropathyYUFENG HUANG; BORDER, Wayne A; LING YU et al.Journal of the American Society of Nephrology. 2008, Vol 19, Num 2, pp 329-338, issn 1046-6673, 10 p.Article

Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor functionSAMSON, Andre L; NEVIN, Simon T; CROUCHER, David et al.Journal of neurochemistry. 2008, Vol 107, Num 4, pp 1091-1101, issn 0022-3042, 11 p.Article

Dual role for plasminogen activator inhibitor type 1 as soluble and as matricellular regulator of epithelial alveolar cell wound healingMAQUERLOT, Francois; GALIACY, Stephane; MALO, Michel et al.The American journal of pathology. 2006, Vol 169, Num 5, pp 1624-1632, issn 0002-9440, 9 p.Article

Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodelingSTEFANSSON, Steingrimur; MCMAHON, Grainne A; PETITCLERC, Eric et al.Current pharmaceutical design. 2003, Vol 9, Num 19, pp 1545-1564, issn 1381-6128, 20 p.Article

Plasminogen promotes sarcoma growth and suppresses the accumulation of tumor-infiltrating macrophagesCURINO, Alejandro; MITOLA, David J; AARONSON, Hannah et al.Oncogene (Basingstoke). 2002, Vol 21, Num 57, pp 8830-8842, issn 0950-9232, 13 p.Article

Endothelial cells inhibit flow-induced smooth muscle cell migration : Role of plasminogen activator inhibitor-1REDMOND, Eileen M; CULLEN, John P; CAHILL, Paul A et al.Circulation (New York, N.Y.). 2001, Vol 103, Num 4, pp 597-603, issn 0009-7322Article